IL17A and chronic obstructive pulmonary disease: Although the role of IL-17 released by innate and adaptive immune cells in the development and progression of COPD has been extensively studied, few investigations have assessed the effects of IL-17 inhibition once the disease is established, and even fewer have explored the long-term outcomes following treatment.